Montelukast Prescribing at THE HOUSE PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,004
Total Quantity
43.6K
NHS Cost
£2.1K
vs National Avg
+46.6%
THE HOUSE PARTNERSHIP prescribed 1,004 items of Montelukast over the last 12 months at a cost of £2,088 to the NHS. This is 46.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
79
Jul 2026
87
Jul 2026
101
Jul 2026
85
Jul 2026
78
Jul 2026
86
Jul 2026
77
Jul 2026
79
Jul 2026
77
Jul 2026
79
Jul 2026
96
Jul 2026
80
Prescribing Details
| Total Items | 1,004 |
|---|---|
| Total Quantity | 43,645 |
| Total NHS Cost | £2,088 |
| Presentations | 4 different forms |
| vs National Average | +46.6% |
Montelukast Prescribing Comparison
| This practice | 1,004 items |
|---|---|
| National average per practice | 685 items |
| Difference | +46.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.